Myoton AS was established as a spin-out from the University of Tartu, Estonia, with the ambitious goal of pioneering the way muscle health can be quantified. The company has been operating since 1999 and is currently headquartered in Tallinn, Estonia.
The founder and visionary behind the Myoton method is Arved Vain, Doctor of Biology, who has devoted most of his professional career to researching and developing solutions for the assessment of tone and biomechanical properties of skeletal muscles.
Years of R&D have led the company to the discovery of innovative MyotonPRO technology that holds the promise of becoming the new widely used standard for muscle assessment. The company is in the process of working with several leading clinicians and scientific institutions around the world to conduct a series of validation and feasibility studies of MyotonPRO in a variety of medical applications.
Myoton holds technology patents in the EPO region, US, JAP, CAN and AU.
Modern medicine has seen many novel solutions to help improve the quality of patient healthcare. However, there are some fields where there has been no major breakthrough, and one such field is the objective and non-invasive assessment of skeletal muscles and other soft biological tissues.
As of today, there are no solutions that are at the same time objective, non-invasive, cost-effective and accessible anytime to everyone.
Myoton has developed a solution for Digital Palpation to fill this gap for muscle and soft tissue assessment. Our mission is to develop a non-invasive and cost-effective technology for the measurement and monitoring of muscles and other soft tissues that is consistent with the principles of preventative and evidence-based medicine. We are dedicated to leading the way to transforming how skeletal muscle properties are measured and monitored.